Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 10870641 Pyridazinones as PARP7 inhibitors
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 5 Jul, 2023
"update inverses"
Golden AI
edited on 5 Jul, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11691969 Pyridazinones as PARP7 inhibtors
0
Edits on 24 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox
(
-1
properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10870641
0
0
Edits on 6 Apr, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 6 Apr, 2023
Infobox
Patent Citations Received
US Patent 11293927 Screening methods for PARP modulators
0
Edits on 31 Mar, 2023
"Entity importer update"
Golden AI
edited on 31 Mar, 2023
Infobox
Is a
Patent
0
Patent Applicant
Ribon Therapeutics
0
Current Assignee
Ribon Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
10870641
0
Date of Patent
December 22, 2020
0
Patent Application Number
16662409
0
Date Filed
October 24, 2019
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10870641
0
Patent Citations
US Patent 10550105 Pyridazinones as PARP7 inhibitors
0
Patent Citations Received
US Patent 11293927 Screening methods for PARP modulators
0
US Patent 11566020 Pyridazinones as PARP7 inhibitors
0
Patent Primary Examiner
Deepak R Rao
0
Edits on 27 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 27 Mar, 2023
Infobox
Patent Citations
US Patent 10550105 Pyridazinones as PARP7 inhibitors
0
Edits on 1 Feb, 2023
"update inverses"
Golden AI
edited on 1 Feb, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11566020 Pyridazinones as PARP7 inhibitors
0
Edits on 27 Sep, 2022
"Entity importer update"
Golden AI
edited on 27 Sep, 2022
Infobox
Is a
Patent
0
Patent Applicant
Ribon Therapeutics
0
Current Assignee
Ribon Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
10870641
0
Date of Patent
December 22, 2020
0
Patent Application Number
16662409
0
Date Filed
October 24, 2019
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10870641
0
Patent Citations
US Patent 10550105 Pyridazinones as PARP7 inhibitors
0
Patent Citations Received
US Patent 11293927 Screening methods for PARP modulators
0
Patent Primary Examiner
Deepak R Rao
0
"update citations for inverse infoboxes"
Golden AI
edited on 26 Sep, 2022
Infobox
Patent Citations
US Patent 10550105 Pyridazinones as PARP7 inhibitors
0
Edits on 17 Jun, 2022
"Entity importer update"
Golden AI
edited on 17 Jun, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10870641
Edits on 6 Apr, 2022
"update inverses"
Golden AI
edited on 6 Apr, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent citations received
US Patent 11293927 Screening methods for PARP modulators
Edits on 8 Feb, 2022
"Created via: Entity Importer"
Golden AI
created this topic on 8 Feb, 2022
Edits made to:
Infobox
(
+10
properties)
US Patent 10870641 Pyridazinones as PARP7 inhibitors
Infobox
Is a
Patent
Patent applicant
Ribon Therapeutics
Current assignee
Ribon Therapeutics
Patent jurisdiction
United States Patent and Trademark Office
Patent number
10870641
Date of patent
December 22, 2020
Patent application number
16662409
Date Filed
October 24, 2019
Patent citations
US Patent 10550105 Pyridazinones as PARP7 inhibitors
Patent primary examiner
Deepak R Rao
Find more entities like US Patent 10870641 Pyridazinones as PARP7 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE